Interferon Sciences Report issue

For profit
Founded: New Brunswick NJ United States (1980)
Status: Acquired by Stem Cell Innovations (2006)

Organization Overview

First Clinical Trial
1999
NCT00002012
First Marketed Drug
1989
interferon alfa-n3 (Alferon-N)
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

INTERFERON SCIENCES

Active Ingredients

Marketed Drugs (1)

interferon alfa-n3 (Alferon-N) (1989)

Drugs in Other Trials (1)

interferon alfa-n3 (Alferon-N) (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1